Radiological and clinical improvement in a patient with COVID-19 pneumonia postconvalescent plasma transfusion: A case report.
Radiol Case Rep
; 15(11): 2171-2174, 2020 Nov.
Article
in En
| MEDLINE
| ID: mdl-32901209
Currently, there are no approved specific antiviral agents for novel coronavirus disease 2019 (COVID-19). Convalescent plasma has not yet been approved for use in patients with COVID-19 infection; however, it is regulated as an investigational product. This is a case report of a 55-year-old male, with COVID-19 pneumonia who has received convalescent plasma as part of a treatment plan which showed significant radiological and clinical improvement post-treatment.
ACR, American College of Radiology; AJR, American Journal of Roentgenology; CECT, COVID-19, coronavirus disease 2019; COVID-19; CRP, C-reactive protein; CT, computed tomography; CXR, chest x-ray; Convalescent plasma transfusion; Crazy paving appearance; ED, emergency department; Groung-glass opacities; HRCT, high-resolution computed tomography; ICU, intensive care unit; NC, nasal cannula; RT-PCR; RT-PCR, Reverse transcription polymerase chain reaction
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Radiol Case Rep
Year:
2020
Document type:
Article
Country of publication:
Netherlands